Printer-friendly
Send to e-mail
PDF versionSALT LAKE CITY -- Utah Attorney General Mark Shurtleff says the state has reached a $24 million civil settlement with Eli Lilly & Co. over claims the drug maker engaged in off-label marketing of the anti-psychotic drug Zyprexa.
Shurtleff's office said Wednesday that it conducted a nearly four-year investigation that showed Indianapolis-based Eli Lilly concealed that Zyprexa has an association with significant weight gain and obesity.
Shurtleff says Zyprexa is approved for the treatment of schizophrenia and certain types of bipolar disorder. But he says the company's sales force illegally promoted Zyprexa for uses not approved by the Food and Drug Administration such as dementia, Alzheimer's, agitation and depression.
Messages were left Wednesday with Eli Lilly seeking comment.
Zyprexa saga
Eli Lilly sells a drug {ZYPREXA} that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place!Eli Lilly has made $38 billion on Zyprexa and it was way oversold and caused diabetes and in some cases sudden death.
Eli Lilly has received a huge criminal fine over their Zyprexa cash cow,add it all up comes to $4.6 billion, in Zyprexa settlements,fines,litigation.
Did you know that Lilly made $ billions last year on diabetic meds, Actos,Humulin and Byetta?
Yes! They sell a drug that can cause diabetes and then turn a profit on the drugs that treat the condition that they may have caused in the first place! ---- Daniel Haszard http://www.zyprexa-victims.com